Driver
Coronary Stent System

Clinical Outcomes

Efficacy of the Driver® Coronary Stent System has been demonstrated both in registries and in a randomized controlled trial.

Confidence in Clinical Outcomes

  • Nearly 600 patients followed to 5 years1
  • More than 3400 patients studied2

References

  1. ENDEAVOR II, Driver control arm.
  2. More than 3400 patients studied includes: E II Driver arm (n=599), Driver registry (n=298), International Driver Registry (n=792), DRASTIC (n=805), DRASTIC II (n=600), Micro Driver registry (n=135), CLASS study (n=202).

Low Target Lesion Revascularization in Registries

  • Comprehensive experience in real-world patients
Driver TLR in Registries

CLASS study 6-mo TLR. Driver Registry 9-mo TLR; International Driver Registry 9-mo TLR.

Durable Efficacy to 5 years in Pivotal Trial

  • 16.3% at 5 years; an increase of just over three percent from 13.1% four years earlier
Low TLR in ENDEAVOR II: Driver Control Arm
Baseline Characteristics
ENDEAVOR II: Driver Control Arm		 n = 599
Diameters (mm) 2.25-3.5
Primary endpoint TVF at 9 mo
RVD (mm) 2.76
Lesion length (mm) 14.38
Pre-procedure MLD (mm) 0.84
Diabetes (%) 22.2
B2/C (%) 79.0
Last updated: 26 Feb 2013
Medtronic Vascular
(877) 526-7890